BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18714179)

  • 1. Downregulation of SS18-SSX1 expression by small interfering RNA inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro.
    Peng C; Guo W; Yang Y; Zhao H
    Eur J Cancer Prev; 2008 Oct; 17(5):392-8. PubMed ID: 18714179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
    Törnkvist M; Natalishvili N; Xie Y; Girnita A; D'Arcy P; Brodin B; Axelson M; Girnita L
    Biochem Biophys Res Commun; 2008 Apr; 368(3):793-800. PubMed ID: 18267106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
    Lubieniecka JM; de Bruijn DR; Su L; van Dijk AH; Subramanian S; van de Rijn M; Poulin N; van Kessel AG; Nielsen TO
    Cancer Res; 2008 Jun; 68(11):4303-10. PubMed ID: 18519690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
    Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K
    Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
    Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA
    Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.
    de Bruijn DR; Allander SV; van Dijk AH; Willemse MP; Thijssen J; van Groningen JJ; Meltzer PS; van Kessel AG
    Cancer Res; 2006 Oct; 66(19):9474-82. PubMed ID: 17018603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma.
    Storlazzi CT; Mertens F; Mandahl N; Gisselsson D; Isaksson M; Gustafson P; Domanski HA; Panagopoulos I
    Genes Chromosomes Cancer; 2003 Jun; 37(2):195-200. PubMed ID: 12696068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
    Xie Y; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
    Cancer Res; 2002 Jul; 62(13):3861-7. PubMed ID: 12097301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
    Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
    Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.
    Xie Y; Skytting B; Nilsson G; Grimer RJ; Mangham CD; Fisher C; Shipley J; Bjerkehagen B; Myklebost O; Larsson O
    Oncogene; 2002 Aug; 21(37):5791-6. PubMed ID: 12173050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1.
    Sun Y; Gao D; Liu Y; Huang J; Lessnick S; Tanaka S
    Oncogene; 2006 Feb; 25(7):1042-52. PubMed ID: 16247461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.
    Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M
    BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
    Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
    Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a new human synovial sarcoma cell line, FU-SY-1, that expresses c-Met receptor and its ligand hepatocyte growth factor.
    Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Isayama T; Naito M; Oda Y; Kaneko Y; Kikuchi M
    Int J Oncol; 2002 Jul; 21(1):17-23. PubMed ID: 12063544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1.
    Tsuda M; Watanabe T; Seki T; Kimura T; Sawa H; Minami A; Akagi T; Isobe K; Nagashima K; Tanaka S
    Oncogene; 2005 Dec; 24(54):7984-90. PubMed ID: 16103879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TLE1 in synovial sarcoma.
    Seo SW; Lee H; Lee HI; Kim HS
    J Orthop Res; 2011 Jul; 29(7):1131-6. PubMed ID: 21319215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial sarcoma is a stem cell malignancy.
    Naka N; Takenaka S; Araki N; Miwa T; Hashimoto N; Yoshioka K; Joyama S; Hamada K; Tsukamoto Y; Tomita Y; Ueda T; Yoshikawa H; Itoh K
    Stem Cells; 2010 Jul; 28(7):1119-31. PubMed ID: 20518020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line.
    Joyner DE; Albritton KH; Bastar JD; Randall RL
    J Orthop Res; 2006 Mar; 24(3):474-80. PubMed ID: 16450387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells.
    Kim DW; Seo SW; Cho SK; Chang SS; Lee HW; Lee SE; Block JA; Hei TK; Lee FY
    J Orthop Res; 2007 Jun; 25(6):820-8. PubMed ID: 17343283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.